Alnylam Pharmaceuticals Inc. (ALNY) Revenue Analysis | Historical Sales Growth & Trends - Stocknear

Alnylam Pharmaceuticals I...

NASDAQ: ALNY · Real-Time Price · USD
446.40
-3.18 (-0.71%)
At close: Sep 26, 2025, 3:59 PM
452.00
1.25%
After-hours: Sep 26, 2025, 07:50 PM EDT

Alnylam Pharmaceuticals Revenue

Alnylam Pharmaceuticals reported an annual revenue of $2.25B, reflecting a 22.97% growth. For the quarter ending June 30, 2025, Alnylam Pharmaceuticals generated $773.69M in revenue.
Revenue (ttm)
2.25B
Revenue Growth
22.97%
Price / Sales Ratio
13.36
Revenue / Employee
1.01M
Employees
2,230
Market Cap
58.51B

Revenue Chart

History

Fiscal Year End Revenue % Change
Dec 31, 2024 2.25B +22.97%
Dec 31, 2023 1.83B +76.23%
Dec 31, 2022 1.04B +22.88%
Dec 31, 2021 844.29M +71.31%
Dec 31, 2020 492.85M +124.28%
Dec 31, 2019 219.75M +193.36%
Dec 31, 2018 74.91M -16.69%
Dec 31, 2017 89.91M +90.66%
Dec 31, 2016 47.16M +14.75%
Dec 31, 2015 41.1M -18.72%
Dec 31, 2014 50.56M +7.20%
Dec 31, 2013 47.17M -29.31%
Dec 31, 2012 66.72M -19.37%
Dec 31, 2011 82.76M -17.28%
Dec 31, 2010 100.04M -0.49%
Dec 31, 2009 100.53M +4.54%
Dec 31, 2008 96.16M +88.94%
Dec 31, 2007 50.9M +89.00%
Dec 31, 2006 26.93M +371.13%
Dec 31, 2005 5.72M +33.61%
Dec 31, 2004 4.28M +2330.68%
Dec 31, 2003 176K +Infinity%
Dec 31, 2002 0 n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.